Qualified participants may receive compensation
An investigational treatment built on the science behind how the body heals itself is being studied for knee osteoarthritis. Adults 40–80 may be eligible.
Fill out the personal health questions below to see if you meet the basic study requirements. Additional eligibility criteria apply. Your answers will be recorded, but your information will only be used for the purposes of this study to determine your eligibility.
The investigational product, PTP-001, is given as a single injection into the knee and is being
evaluated in this FDA-regulated clinical trial to see if it may help improve pain and joint function in
people with osteoarthritis. Click for more details
This investigational treatment is designed to deliver biologic factors associated with tissue repair and regeneration — capturing important signals commonly associated with stem cells, without using living cells. Administered as a single knee injection, it is designed to target your knee osteoarthritis at its source.
Yes, this study is placebo-controlled. Participants will have a 50% chance of receiving the investigational treatment and a 50% chance of receiving a placebo (an inactive saline vehicle) injection. Neither you nor the medical team will know which injection you receive.
Participation lasts for just over 12 months. This includes a screening period of up to 4 weeks, a single treatment day, and follow-up visits at 2 weeks, 3 months, 6 months, 9 months, and 12 months.
You will need to temporarily stop your current pain medications (called a washout period) before certain study visits so your natural pain levels can be accurately measured. During the study, you will be asked to use acetaminophen as your primary rescue pain medication.
No. If you meet the eligibility criteria and choose to participate, all study-related care, including the investigational injection, X-rays, and medical evaluations, will be provided at no cost to you.
Please note: 1nHealth may store your data in a confidential and secure database. That personal information will never be shared or sold with any other persons or organizations not associated with 1nHealth. 1nHealth may/will use personal information to contact you directly by phone and/or email for matters related to potential participation in clinical trials, studies, and projects for which the potential participant may qualify. See our Privacy Policy for more details.